Mon, April 17, 2017
Fri, April 14, 2017
Thu, April 13, 2017

Madhu Kumar Reiterated (AKTX) at Strong Sell with Increased Target to $130 on, Apr 17th, 2017

Madhu Kumar of Chardan Capital, Reiterated "Akari Therapeutics, Plc" (AKTX) at Strong Sell with Increased Target from $100 to $130 on, Apr 17th, 2017.

Madhu, nor any peers, have made any analyst calls on AKTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30